Sisters of Mercy University Hospital   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Cork Ireland (1857)

Organization Overview

First Clinical Trial
2010
NCT01178931
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Clinical Hospital Centre "Sisters of Mercy" | Department of Human Reproduction, University Hospital Center Sisters of Mercy | GI Physiology Laboratory, Mercy University Hospital | Sisters of Mercy University Hospital | University Hospital Center Sisters of Mercy

Active Ingredients

Drugs in Phase 3 Trials (1)

lactobacillus reuteri (1 trial)

Drugs in Phase 2 Trials (1)

bifidobacterium animalis (1 trial)

Drugs in Other Trials (3)

dydrogesterone (gynorest) (1 trial)

progesterone (progestasert) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abdominal Pain (Phase 3)

Constipation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5